References
- Muller-Eberhard J. Complement. Annu. Rev. Biochem. 1975; 44: 697
- Fearon D. T., Austen K. F. The alternative pathway of complement – a system for host resistance to microbial infection. N. Engl. J. Med. 1980; 303: 259
- Porter R. R. The complex proteases of the complement system. Proc. R: Soc. London 1980; 210: 477
- Bokisch V. A., Dierich M. P., Müller-Eberhard H. J. Third component of complement (C3): structural properties in relation to functions. Proc. Natl. Acad. Sci. U.S.A. 1975; 72: 1989
- Nilsson U. R., Mandle R. J., Jr., Mapes J. A. Human C3 and C5: Sub-unit structure and modifications by trypsin and C4,2-C4,2,3. J. Immunol. 1975; 114: 815
- Schreiber R. D., Müller-Eberhard H. J. Fourth component of human complement: Description of a three polypeptide chain structure. J. Exp. Med. 1974; 140: 1324
- Mayer M. M. Mechanism of cytolysis by complement. Proc. Natl. Acad. Sci. U.S.A. 1972; 69: 2954
- Borsos T., Rapp H. R. Hemolysin titration based on fixation of the activated first component of complement: Evidence that one molecule of hemolysin suffices to sensitize an erythrocyte. J. Immunol. 1965; 95: 559
- Humphrey J. H., Dourmashkin R. R. Electron microscope studies of immune cell lysis. Complement, CIBA Found. Symp., J. and A., Churchill, London, 1965; 175
- Augener W., Grey H. M., Cooper N. R., Müller-Eberhard H. J. The reaction of monomeric and aggregated immunoglobulins with C1. Immunochemistry 1971; 8: 1011
- Humphrey J. H., Dourmashkin R. R. The lesions in cell membranes caused by complement. Adv. Immunol. 1969; 11: 75
- Green H., Barrow P., Goldberg B. Effect of antibody and complement on permeability control in ascites tumor cells and erythrocytes. J. Exp. Med. 1959; 110: 699
- Pillemer L., Blum L., Lepow I. H., Ross O. A., Todd E. W., Wardlaw A. C. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science 1954; 120: 279
- Gewurz H., Shin H. S., Mergenhagen S. E. Interactions of the complement system with endotoxin lipopolysaccharides: Consumption of each of the six terminal complement components. J. Exp. Med. 1968; 128: 1049
- Flexner S., Noguchi H. Snake venom in relation to hemolysis, bacteriolysis, and toxicity. J. Exp. Med. 1903; 6: 277
- Götze O., Müller-Eberhard H. J. The alternative pathway of complement activation. Adv. Immunol. 1976; 24: 1
- World Health Organization. Nomenclature of the alternative activating pathway of complement. Eur. J. Immunol. 1981; 11: 668
- Götze O., Müller-Eberhard H. J. Paroxysmal nocturnal hemoglobinuria: Hemolysis initiated by the C3 activator system. N. Engl. J. Med. 1972; 286: 180
- Poskitt T. R., Fortwengler H. P., Lunskis B. J. Activation of the alternative complement pathway by autologous red cell stroma. J. Exp. Med. 1973; 138: 715
- Bokisch V. A., Müller-Eberhard H. J., Cochrane C. G. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J. Exp. Med. 1969; 129: 1109
- Sim R. B., Twose T. M., Paterson D. S., Sim E. The covalent-binding reaction of complement component C3. Biochem, J. 1981; 193: 115
- Law S. K., Levine R. P. Interaction between the third complement protein and cell surface macromolecules. Proc. Natl. Acad. Sci. U.S.A. 1977; 74: 2701
- Ruddy S., Austen K. F. C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b. J. Immunol. 1971; 107: 742
- Weiler J. M., Daha M. R., Austen K. F., Fearon D. T. Control of the amplification convertase of complement by the plasma protein, βIH. Proc. Natl. Acad. Sci. U.S.A. 1976; 73: 3268
- Pangbura M. K., Schreiber R. D., Müller-Eberhard H. J. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein βH for cleavage of C3b and C4b in solution. J. Exp. Med. 1977; 146: 257
- Law S. K., Fearon D. T., Levine R. P. Action of the C3b-inactivator on cell-bound C3B. J. Immunol. 1979; 122: 759
- Carlo J. R., Ruddy S., Studer E. J., Conrad D. H. Complement receptor binding of C3b-coated cells treated with C3b inactivator, βIH globulin and trypsin. J. Immunol. 1979; 123: 523
- Gaither T. A., Hammer C. H., Frank M. M. Studies of the molecular mechanisms of C3B inactivation and a simplified assay of βIH and the C3b inactivator (C3bINA). J. Immunol. 1979; 123: 1195
- Harrison R. A., Lachmann P. J. The physiological breakdown of the third component of human complement. Mol. Immunol. 1980; 17: 9
- Lachmann P. J., Oldroyd R. G., Milstein C., Wright B. W. Three rat monoclonal antibodies to human C3. Immunology 1980; 41: 503
- Lachmann P. J., Pangburn M. K., Olkroyd R. G. Breakdown of C3 after complement activation. J. Exp. Med. 1982; 156: 205
- Petz L. D., Garratty G. Acquired Immune Hemolytic Anemias. Churchill Livingstone, New York 1980
- Waller M. V., Vaughan J. H. The use of anti-Rh sera for demonstrating agglutination activating factor in rheumatoid arthritis. Proc. Soc. Exp. Biol. Med. 1956; 92: 198
- Ayland J., Horton M. A., Tippett P., Waters A. H. Complement binding anti-D made in a D variant woman. Vox Sang. 1978; 34: 40
- Kline W. E., Sullivan C. M., Pope M., Bowman R. J. An example of a naturally occurring anti-cE (Rh27) that binds complement. Vox Sang 1982; 43: 335
- Freedman J., Massey A., Chaplin H., Monroe M. C. Assessment of complement binding by anti-D and anti-M antibodies employing labelled antiglobulin antibodies. Br. J. Haematol. 1980; 45: 309
- Waller M., Lawler S. D. A study of the properties of the rhesus antibody (Ri) diagnostic for rheumatoid factor and its application to Gm grouping. Vox Sang. 1962; 7: 591
- Hughes-Jones N. C. Blood Transfusion in Clinical Medicine, 5th ed. Blackwell Scientific, Oxford 1972; 282, cited in Mollison, P. L.
- Hsu T. C. S., LeDoux R. G., Sussman I. I., Steinberg J., Sawitsky A. Ripley-like anti-Rh associated with red blood cell-bound IgG aggregates. Transfusion 1979; 19: 25
- Mollison P. L. Blood Transfusion in Clinical Medicine, 5th ed. Blackwell Scientific, Oxford 1972
- Rosse W. F. Fixation of the first component of complement (C'la) by human antibodies. J. Clin. Invest. 1968; 47: 2430
- Garratty G., unpublished observations.
- Garratty G., Petz L. D. Drug induced immune hemolytic anemia. Am. J. Med. 1975; 58: 398
- Ehlenberger A. G., Nussenzweig V. Immunologically mediated phagocytosis: role of C3 and Fc receptors. Clinical Evaluation of Immune Function in Man, S. D. Litwin, C. L. Christian, G. W. Siskind. Grune & Stratton, New York 1976; 47
- Ross G. D. Analysis of the different types of leukocyte membrane complement receptors and their interaction with the complement system. J. Immunol. Methods 1980; 37: 197
- Wellek B., Hahn H. H., Opferkuch W. Evidence for macrophage C3d-receptor active in phagocytosis. J. Immunol. 1975; 114: 1643
- Brown D. L., Lachmann P. J., Dacie J. V. The in vivo behavior of complement-coated red cells: Studies in C6-deficient, C3-depleted and normal rabbits. Clin. Exp. Immunol. 1970; 7: 401
- Atkinson J. P., Frank M. M. Studies on the in vivo effects of antibody interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man. J. Clin. Invest. 1974; 54: 339
- Müller-Eberhard H. J. Complement and phagocytosis. The Phagocytic Cell in Host Resistance, J. A. Bellanti, H. D. Delbert. Raven Press, New York 1975; 87
- Bianco C. Plasma membrane receptors for complement. Comprehensive Immunology, R. A. Good, S. B. Day. Plenum Press, New York 1977
- Griffin F. M., Jr., Bianco C., Silverstein S. C. Characterization of the macrophage receptor for complement and demonstration of its functional independence from the receptor for the Fc portion of immunoglobulin. G. J. Exp. Med. 1975; 141: 1269
- Reynolds H. Y., Atkinson J. P., Newball H. H., Frank M. M. Receptors for immunoglobulin and complement on human alveolar macrophages. J. Immunol. 1975; 114: 1813
- Ross G. D. Lymphocyte complement receptors and their relationship to other membrane receptors. Clinical Evaluation of Immune Function in Man, S. D. Litman. Grune and Stratton, New York 1976; 27
- Lewis S. M., Dacie J. V., Szur L. Mechanisms of haemolysis in the cold-haemagglutinin syndrome. Br. J. Haematol. 1960; 6: 164
- Mollison P. L. The role of complement in haemolytic processes in vivo. Complement, G. E. W. Wolstenholme, J. Knight. J. and A. Churchill, London 1965; 323
- Schreiber A. D., Frank M. M. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. In vivo effects of IgG and IgM complement fixing sites. J. Clin. Invest. 1972; 51: 575
- Schreiber A. D., Frank M. M. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum. J. Clin. Invest. 1972; 51: 583
- Bianco C., Griffin F. M., Jr., Silverstein S. C. Studies of the macrophage complement receptor. J. Exp. Med. 1975; 141: 1278
- Griffin F. M., Jr., Griffin J. A., Leider J. E., Silverstein S. C. Studies on the mechanism of phagocytosis. I. Requirements for circumferential attachment of particle-bound ligands to specific receptors on the macrophage plasma membrane. J. Exp. Med. 1975; 142: 1263
- Rosse W. F., DeBorsfleury A., Bessis M. The interaction of phagocytic cells and red cells modified by immune reactions. Comparison of antibody and complement coated red cells. Blood Cells 1975; 1: 345
- Scornick J. C., Drewinko B. Receptors for IgG and complement in human spleen lymphoid cells. Preferential binding of particulate immune complexes through complement receptors. J. Immunol. 1975; 115: 1223
- Nicholson G. C., Masouredis S. P., Singer S. J. Quantitative two dimensional ultrastructural distribution of Rho(D) antigenic sites on human erythrocyte membranes. Proc. Natl. Acad. Sci. 1971; 68: 1416
- Atkinson J. P., Frank M. M. Role of complement in the pathophysiology of hematologic diseases. Prog. Hematol. 1977; 10: 211
- Jaffe C. J., Atkinson J. P., Frank M. M. The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man. J. Clin. Invest. 1976; 58: 942
- Evans R. S., Turner E., Bingham M. Studies with radioiodinated cold agglutinins of ten patients. Am. J. Med. 1965; 38: 378
- Munn L. R., Chaplin H. Rosette formation by sensitized human red cells – Effects of source of peripheral leukocyte monolayers. Vox Sang 1977; 33: 129
- Logue G., Rosse W. Immunologic mechanisms in autoimmune hemolytic disease. Semin. Hematol. 1976; 13: 277
- Fischer J., Petz L. D., Garratty G. Quantitation of erythrocyte bound C3 on human red cells sensitized in vitro or in vivo. Blood 1972; 40: 968
- Coombs R. R. A., Mourant A. E., Race R. R. A new test for the detection of weak and “incomplete” Rh agglutinins. Br. J. Exp. Pathol. 1945; 26: 255
- Dacie J. V. Differences in the behavior of sensitised red cells to agglutination by antiglobulin sera. Lancet 1951; 2: 954
- Dacie J. V. Acquired hemolytic anemia. With special reference to the antiglobulin (Coombs) reaction. Blood 1953; 8: 813
- Cutbush M., Crawford H., Mollison P. L. Observations on antihuman globulin sera. Br. J. Haematol. 1955; 1: 410
- Dacie J. V., Crookston J. H., Christenson W. N. “Incomplete” cold antibodies: role of complement in sensitization to antiglobulin serum by potentially haemolytic antibodies. Br. J. Haematol. 1957; 3: 77
- Harboe M., Müller-Eberhard H. J., Fudenberg H., Polley M. J., Mollison P. L. Identification of the components of complement participating in the antiglobulin reaction. Immunology 1963; 6: 412
- Jenkins G. C., Polley M. J., Mollison P. L. Role of C4 in the antiglobulin reaction. Nature (London) 1960; 186: 482
- Kerr R. O., Dalmasso A. P., Kaplan M. E. Erythrocyte-bound C5 and C6 in autoimmune hemolytic anemia. J. Immunol. 1971; 107: 1209
- Garratty G., Petz L. D. The significance of red cell bound complement components in development of standards and quality assurance for the anti-complement components of antiglobulin sera. Transfusion 1976; 16: 297
- Polley M. J., Mollison P. L. The role of complement in the detection of blood group antibodies. Special reference to the antiglobulin test. Transfusion 1961; 1: 9
- Garratty G., Petz L. D. An evaluation of commercial antiglobulin sera with particular reference to their anticomplement properties. Transfusion 1971; 11: 79
- Chaplin H. Antiglobulin testing (1968) – are we satisfied with what we are doing?. Proc. 21st Annu. Meet. Am. Assoc. Blood Banks. American Association of Blood Banks, Washington, DC 1968; 65
- Petz L. D., Garratty G. Antiglobulin sera – past, present, and future. Transfusion 1978; 18: 257
- Garratty G. Basic mechanisms of in vivo cell destruction. A Seminar on Immune-Mediated Cell Destruction. American Association of Blood Banks, Washington, DC 1981; 1
- Stratton F., Gunson H. H., Rawlinson V. I. Complement fixing antibodies in relation to hemolytic disease of the newborn. Transfusion 1965; 5: 216
- Dorner I., Moore J. A., Chaplin H. Combined maternal erythrocyte autosensitization and maternofetal Jka incompatibility. Transfusion 1974; 14: 212
- Chaplin H., Avioli L. V. Autoimmune hemolytic anemia. Arch. Intern. Med. 1977; 137: 346
- Burkhart P., Rosenfield R. E., Hsu T. C. S., Wong K. Y., Nusbacher J., Shaikh S. H., Kochwa S. Instrumented PVP-augmented antiglobulin tests. I. Detection of allogeneic antibodies coating otherwise normal erythrocytes. Vox Sang. 1974; 26: 289
- Szymanski I., Odgren P. R., Fortier N. L., Snyder L. M. Red blood cell associated IgG in normal and pathologic states. Blood 1980; 55: 48
- Kay M. M. B. Mechanism of removal of senescent cells by human macrophages in situ. Proc. Natl. Acad. Sci. U.S.A. 1975; 72: 3521
- Kay M. M. B. Role of physiologic autoantibody in the removal of senescent human red cells. J. Supramol. Struct. 1978; 9: 555
- Alderman E. M., Fudenberg H. H., Lovins R. E. Binding of immunoglobulin classes to subpopulations of human red blood cells separated by density-gradient centrifugation. Blood 1980; 55: 817
- Graham H. A., Davies D. M., Jr., Brower C. E. Detection of C3b and C3d on red cell membranes. Int. Symp. Nature and Significance of Complement Activation. Ortho Research Institute of Medical Sciences, Raritan, NJ 1976; 197
- Rosenfield R. E., Jagathambal. Antigenic determinants of C3 and C4 complement components on washed erythrocytes from normal persons. Transfusion 1978; 18: 517
- Chaplin H., Nasongkla M., Monroe M. C. Quantitation of red blood cell-bound C3d in normal subjects and random hospitalized patients. Br. J. Haematol. 1981; 48: 69
- Allan J., Garratty G. Positive direct and antiglobulin tests in normal blood donors. Proc. 16th Congr. Int. Soc. Blood Transfus., Montreal, 1980; 150
- Weiner W. “Coombs positive normal people”. Proc. 10th Congr. Int. Soc. Blood Transfus., Stockholm, 1964; 35
- Worlledge S. M. The interpretation of a positive direct antiglobulin test. Br. J. Haematol. 1978; 39: 157
- Kay N. E., Anderson K. Direct antiglobulin “Coombs” test. N.Y. State J. Med. July, 1978; 1244
- Gorst D. W., Rawlinson V. I., Merry A. H., Stratton F. Positive direct antiglobulin test in normal individuals. Vox Sang 1980; 38: 99
- Lau P., Haesler W. E., Wurzel H. A. Positive direct reaction in a patient population. Am. J. Clin. Pathol. 1976; 65: 368
- Freedman J. False-positive antiglobulin tests in healthy subjects and in hospital patients. J. Clin. Pathol. 1979; 32: 1014
- Judd W. J., Butch S. H., Oberman H. A., Steiner E. A., Bauer R. C. The evaluation of a positive direct antiglobulin test in pretransfusion testing. Transfusion 1980; 20: 17
- Freedman J., Ho M., Barefoot C. Red blood cell-bound C3d in selected hospital patients. Transfusion 1982; 22: 515
- Harris J. P., Tegoli J., Swanson J., Fischer N., Gavin J., Noades J. A. A nebulous antibody responsible for cross-matching difficulties (Chido). Vox Sang 1967; 12: 140
- Longster G., Giles C. M. A new antibody specificity, anti-Rga, reacting with a red cell and serum antigen. Vox Sang 1976; 30: 175
- Middleton J., Crookston M. C., Falk J. A., Robson E. B., Cook P. J. L., Batchelor J. R., Bodmer J., Ferrara G. B., Festenstein H., Harris R., Kissmeyer-Nielseon F., Lawler S. D., Sachs J. A., Wolf E. Linkage of Chido and HL-A. Tissue Antigens 1974; 4: 366
- O'Neill G. J., Yang S. Y., Tegoli J., Berger R., Dupont B. Chido and Rodgers blood groups are distinct antigenic components of human complement C4. Nature (London) 1978; 273: 668
- Tilley C. A., Romans D. G., Crookston M. C. Localization of Chido and Rodgers determinants to a tryptic C4d fragment of human C4. Transfusion 1978; 18: 622
- Chu V. F., Marsh W. L., Gigli I. Chido and Rodgers antigenic determinant on the fourth component of human complement. J. Immunol. 1982; 128: 181
- Stratton F., Gunson H. H., Rawlinson V. I. The preparation and uses of antiglobulin reagents with special reference to complement fixing blood group antibodies. Transfusion 1962; 2: 135
- Polley M. J., Mollison P. L., Soothill J. F. The role of 19S gamma-globulin blood-group antibodies in the antiglobulin reaction. Br. J. Haematol. 1962; 8: 149
- Adinolfi M., Polley M. J., Hunter D. A., Mollison P. L. Classification of blood-group antibodies as B2M or gamma globulin. Immunology 1962; 5: 566
- Stratton F., Smith D. S., Rawlinson V. I. Value of gel filtration on Sephadex G-200 in the analysis of blood group antibodies. J. Clin. Pathol. 1968; 21: 708
- Stratton F., Smith D. S., Rawlinson V. I. 19S gamma M followed by 7S gamma G anti-Jka antibodies associated with pregnancy. Clin. Exp. Immunol. 1968; 3: 81
- Stratton F. Recent observations on the antiglobulin test. Wadley Med. Bull. 1975; 5: 182
- Stratton F., Rawlinson V. I. C3 components on red cells under various conditions. Int. Symp. Nature and Significance of Complement Activation. Ortho Research Institute of Medical Sciences, Raritan, NJ 1976; 113
- Sherwood G. K., Haynes B. F., Rosse W. F. Hemolytic transfusion reactions caused by failure of commercial antiglobulin reagents to detect complement. Transfusion 1976; 16: 417
- Engelfriet C. P., personal communication
- Issitt P. D., Smith T. R. Evaluation of antiglobulin reagents. A Seminar on Performance Evaluation. American Association of Blood Banks, Washington, DC 1976; 25
- Petz L. D. Complement in immunohematology and in neurologic disorders. Int. Symp. Nature and Significance of Complement Activation. Ortho Research Institute of Medical Sciences, Raritan, NJ 1977; 87
- Giblett E. R. Blood group alloantibodies: an assessment of some laboratory practices. Transfusion 1977; 17: 299
- Beck M. L., Marsh W. L. Complement and the antiglobulin test. Transfusion 1977; 17: 529
- Garratty G. The effects of storage and heparin on the activity of serum complement with particular reference to the detection of blood group antibodies. Am. J. Clin. Pathol. 1970; 54: 531
- Chaplin H., Freedman J., Massey A., Monroe M. C. Characterization of red blood cells strongly coated in vitro by C3 via the alternative pathway. Transfusion 1980; 20: 256
- Chaplin H., Hoffmann N. L. Radioimmunoassay evaluation of anti-C3d reactivity in broad spectrum commercial antiglobulin reagents. Transfusion 1982; 22: 6
- Petz L. D., Branch D. R., Garratty G., Grumet F. C., Howard J. The significance of the anticomplement component of antiglobulin serum (AGS) in compatibility testing. Transfusion 1981; 21: 633
- Howard J. E., Winn L. C., Gottlieb C. E., Grumet F. C., Garratty G., Petz L. D. Clinical significance of the anticomplement component of antiglobulin antisera. Transfusion 1982; 22: 269
- Nasongkla M., Hummert J., Chaplin H. Weak “false positive” direct antiglobulin test reactions with polyspecific antiglobulin reagents. Transfusion 1982; 22: 273
- Issitt P. D., Issitt C. H., Wilkinson S. L. Evaluation of commercial antiglobulin sera over a two-year period. II. Anti-IgG and anti-IgM levels and undesirable contaminating antibodies. Transfusion 1974; 14: 103
- Freedman J., Chaplin H., Mollison P. L. Further observations on the preparation of antiglobulin reagents reacting with C3d and C4d on red cells. Vox Sang 1977; 33: 21
- Issitt P. D. Antibodies reactive at 30 centrigrade, room temperature, and below. Clinically Significant and Insignificant Antibodies. American Association of Blood Banks, Washington, DC 1979; 13
- Mollison P. L. The clinical significance of red cell alloantibodies (and autoantibodies) in blood transfusion. Safety in Transfusion Practices. College of American Pathologists, Chicago 1982; 131
- Walker R. H. Is a crossmatch using the indirect antiglobulin test necessary for patients with a negative antibody screen. Safety in Transfusion Practices. College of American Pathologists, Chicago 1982; 95
- Garratty G. Predicting the clinical significance of alloantibodies and determining the in vivo survival of transfused red cells. Clinical and Serological Aspects of Blood Transfusion. American Association of Blood Banks, Washington, DC 1982; 91
- International Society of Blood Transfusion, Working Party on the standardization of antiglobulin reagents of the expert panel of serology. Vox Sang 1980; 38: 178